Engineering Hope: Dr. Angie Belcher’s Mission to Detect Ovarian Cancer Early
“We want to help give women and their families the ability to live the full lives they were meant to live.” – Dr. Angie Belcher, PhD
Dr. Angie Belcher, a leading researcher at MIT and Tina’s Wish funded researcher, has dedicated her career to using nanoscience to solve some of the world’s most complex health challenges. Her current focus: developing groundbreaking technologies to enable the early detection of ovarian cancer.
In her lab, Dr. Belcher and her team are combining the power of light, artificial intelligence, and nanotechnology to identify tumors smaller than a millimeter – lesions invisible to the human eye. By bringing together engineers, cancer biologists, and data scientists, her team is advancing innovative tools that could transform how ovarian cancer is detected and diagnosed.
Through collaboration with organizations like Tina’s Wish, Dr. Belcher is helping to push the boundaries of what’s possible in cancer detection. Her work embodies innovation, compassion, and an unwavering commitment to improving outcomes for women and their families affected by ovarian cancer.